Sat Oct 25 18:08:10 SGT 2014  
    Genital Warts, Malaysia
HIV STD TESTING SINGAPORE™
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital Warts, Malaysia | HIV STD TESTING SINGAPORE™

Summary

Genital Warts, Malaysia | HIV STD TESTING SINGAPORE™ @beautymalaysia_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Malaysia - Private and confidential service. Definitions, references, and latest news.

Keywords: Genital Warts Malaysia, Malaysia Genital Warts, Genital Warts.

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts, Malaysia
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

Expression of Yes-Associated Protein in Cervical Squamous Epithelium Lesions
Fri, 24 Oct 2014 21:11:30 +0100 | International Journal of Gynecological Cancer
ConclusionThis study suggested that YAP could function as a predictive marker in CIN and cervical cancer. YAP expression, in combination of HPV, might facilitate the identification of precancerous cervical lesions. (Source: International Journal of Gynecological Cancer)

Increasing Human Papillomavirus (HPV) Vaccination in Boys: Reducing Health Disparities through Advanced Pediatric Nursing Practice
Fri, 24 Oct 2014 09:47:22 +0100 | Journal of Pediatric Health Care
The purpose of this study was to examine parents’ knowledge of HPV and predictors of Human Papillomavirus (HPV) vaccination for their sons’ ages 9 to 13 years of age. (Source: Journal of Pediatric Health Care)

Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging
Fri, 24 Oct 2014 00:00:00 +0100 | Radiotherapy and Oncology
Due to the established role of the human papillomavirus (HPV), the optimal treatment for oropharyngeal carcinoma is currently under debate. We evaluated the most important determinants of treatment outcome to develop a multifactorial predictive model that could provide individualized predictions of treatment outcome in oropharyngeal carcinoma patients. (Source: Radiotherapy and Oncology)

The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck
Thu, 23 Oct 2014 00:00:00 +0100 | Annals of Oncology
Conclusions

Best practices in the management of the psycho-oncologic aspects of head and neck cancer patients: recommendations from the European Head and Neck Cancer Society Make Sense Campaign
Thu, 23 Oct 2014 00:00:00 +0100 | Annals of Oncology
This article reviews the key points for delivering emotional support to SCCHN patients at each stage of their care. Emotional problems cannot be ignored in SCCHN patients if optimal outcomes are to be achieved, particularly as therapeutic options extend overall survival for many patients. Health care professionals must be able to implement efficient screening for psychological distress to support patient's compliance to their care and treatment. They must also be able to recognize when to refer patients at risk for pharmacological and/or psychotherapeutic interventions. (Source: Annals of Oncology)

Expression of nucleic acid‐sensing Toll‐like receptors predicts HPV16 clearance associated with an E6‐directed cell‐mediated response
Thu, 23 Oct 2014 00:00:00 +0100 | International Journal of Cancer
We examined here the association between TLR expression and clearance of HPV16 infections following periods of persistence, using longitudinal TLR measurements and a time‐to‐clearance analysis, as well as the interaction between TLRs and adaptive, cell‐mediated responses involved in clearance. TLR2, TLR3, TLR7, TLR8, and TLR9 mRNA expression were measured in cervical cytobrush samples by quantitative PCR. Responses to the HPV16 E6 and E7 oncoproteins were measured by an interferon‐γ immunospot assay. Bivariable and multivariable Cox proportional hazard models were used to estimate the effect of TLRs on HPV16 clearance. Higher expression of TLR3 or TLR7 at an HPV16‐positive visit was a significant (p ≤ 0.05) predictor of clearance by the following visit, in both unadjusted and ...

Optimization of HPV DNA detection in urine by improving collection, storage, and extraction
Wed, 22 Oct 2014 16:54:14 +0100 | European Journal of Clinical Microbiology and Infectious Diseases
Abstract

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
Tue, 21 Oct 2014 20:17:11 +0100 | Cancer
CONCLUSIONSThis relatively large cohort study demonstrates that a high CNC and a high CMC independently predict inferior OS and RFS, whereas a high CLC predicts better RFS and marginally better OS in HPV+ OPC patients. This association was not apparent in HPV– patients. Cancer 2014. © 2014 American Cancer Society. (Source: Cancer)

Uptake of Human Papillomavirus Vaccine Among Adolescent Males and Females: Immunization Information System Sentinel Sites, 2009–2012
Tue, 21 Oct 2014 00:00:00 +0100 | Academic Pediatrics
Conclusions HPV vaccination coverage increased among adolescents between 2009 and 2012. However, increases among girls were small, and coverage for boys and girls remained below target levels. (Source: Academic Pediatrics)

No link between vaccination and risk of MS
Mon, 20 Oct 2014 23:00:00 +0100 | Multiple Sclerosis Trust
This new study found no long term association between any vaccines, including hepatitis B and HPV (human papillomavirus), and an increased risk of developing MS, for up to three years following vaccination. (Source: Multiple Sclerosis Trust)